Loading candles…
Par Drugs & Chemicals Ltd, incorporated in 1982, operates in the pharmaceutical and healthcare industries. The company manufactures Active Pharmaceutical Ingredients (APIs) and Fine Chemicals, with a primary focus on antacid molecules. It is recognized as one of the major producers of magnesium and aluminum-based antacid compounds in India. Par Drugs & Chemicals serves both the Indian market and international markets. The company does not disclose specific details about its headquarters, founders, key management, subsidiaries, notable projects, or stock exchange listings.
This page is a live market overview for PAR DRUGS AND CHEM LTD (PAR) on the NSE. As a listed security, PAR DRUGS AND CHEM LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for PAR before placing trades on tick2trade.
As of the latest feed, PAR last traded at ₹133 on NSE, up ₹1.69 (1.29%) from the previous close of ₹131.31. Today's session range is ₹128.11 – ₹134.49, against a 52-week band of ₹78.05 – ₹180. Traded volume today stands at 3.68K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for PAR in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether PAR is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for PAR DRUGS AND CHEM LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in PAR. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated PAR option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Other | To consider other business matters | 22 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 8 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 14 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 10 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 13 Nov 2025 |
| Other | To consider other business matters | 29 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 7 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 8 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.